Literature DB >> 18346985

A rare mutation in ABCC8/SUR1 leading to altered ATP-sensitive K+ channel activity and beta-cell glucose sensing is associated with type 2 diabetes in adults.

Andrei I Tarasov1, Tamara J Nicolson, Jean-Pierre Riveline, Tarvinder K Taneja, Stephen A Baldwin, Jocelyn M Baldwin, Guillaume Charpentier, Jean-François Gautier, Philippe Froguel, Martine Vaxillaire, Guy A Rutter.   

Abstract

OBJECTIVE: ATP-sensitive K(+) channels (K(ATP) channels) link glucose metabolism to the electrical activity of the pancreatic beta-cell to regulate insulin secretion. Mutations in either the Kir6.2 or sulfonylurea receptor (SUR) 1 subunit of the channel have previously been shown to cause neonatal diabetes. We describe here an activating mutation in the ABCC8 gene, encoding SUR1, that is associated with the development of type 2 diabetes only in adults. RESEARCH DESIGN AND METHODS: Recombinant K(ATP) channel subunits were expressed using pIRES2-based vectors in human embryonic kidney (HEK) 293 or INS1(832/13) cells and the subcellular distribution of c-myc-tagged SUR1 channels analyzed by confocal microscopy. K(ATP) channel activity was measured in inside-out patches and plasma membrane potential in perforated whole-cell patches. Cytoplasmic [Ca(2+)] was imaged using Fura-Red.
RESULTS: A mutation in ABCC8/SUR1, leading to a Y356C substitution in the seventh membrane-spanning alpha-helix, was observed in a patient diagnosed with hyperglycemia at age 39 years and in two adult offspring with impaired insulin secretion. Single K(ATP) channels incorporating SUR1-Y356C displayed lower sensitivity to MgATP (IC(50) = 24 and 95 micromol/l for wild-type and mutant channels, respectively). Similar effects were observed in the absence of Mg(2+), suggesting an allosteric effect via associated Kir6.2 subunits. Overexpression of SUR1-Y356C in INS1(832/13) cells impaired glucose-induced cell depolarization and increased in intracellular free Ca(2+) concentration, albeit more weakly than neonatal diabetes-associated SUR1 mutants.
CONCLUSIONS: An ABCC8/SUR1 mutation with relatively minor effects on K(ATP) channel activity and beta-cell glucose sensing causes diabetes in adulthood. These data suggest a close correlation between altered SUR1 properties and clinical phenotype.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18346985      PMCID: PMC6101196          DOI: 10.2337/db07-1547

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  52 in total

1.  Structure of a bacterial multidrug ABC transporter.

Authors:  Roger J P Dawson; Kaspar P Locher
Journal:  Nature       Date:  2006-08-30       Impact factor: 49.962

2.  Identification of the PIP2-binding site on Kir6.2 by molecular modelling and functional analysis.

Authors:  Shozeb Haider; Andrei I Tarasov; Tim J Craig; Mark S P Sansom; Frances M Ashcroft
Journal:  EMBO J       Date:  2007-08-02       Impact factor: 11.598

3.  A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.

Authors:  Peter Proks; Amanda L Arnold; Jan Bruining; Christophe Girard; Sarah E Flanagan; Brian Larkin; Kevin Colclough; Andrew T Hattersley; Frances M Ashcroft; Sian Ellard
Journal:  Hum Mol Genet       Date:  2006-04-13       Impact factor: 6.150

4.  An adenylate kinase is involved in KATP channel regulation of mouse pancreatic beta cells.

Authors:  D U Schulze; M Düfer; B Wieringa; P Krippeit-Drews; G Drews
Journal:  Diabetologia       Date:  2007-08-18       Impact factor: 10.122

Review 5.  Generating new candidate genes for neonatal diabetes: functional and genetic studies of insulin secretion in type 2 diabetes.

Authors:  Guy A Rutter
Journal:  Endocr Dev       Date:  2007

6.  A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1.

Authors:  Hanna Huopio; Timo Otonkoski; Ilkka Vauhkonen; Frank Reimann; Frances M Ashcroft; Markku Laakso
Journal:  Lancet       Date:  2003-01-25       Impact factor: 79.321

Review 7.  K(ATP) channels and insulin secretion: a key role in health and disease.

Authors:  F M Ashcroft
Journal:  Biochem Soc Trans       Date:  2006-04       Impact factor: 5.407

8.  Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes.

Authors:  Anna L Gloyn; Michael N Weedon; Katharine R Owen; Martina J Turner; Bridget A Knight; Graham Hitman; Mark Walker; Jonathan C Levy; Mike Sampson; Stephanie Halford; Mark I McCarthy; Andrew T Hattersley; Timothy M Frayling
Journal:  Diabetes       Date:  2003-02       Impact factor: 9.461

9.  Two sites for adenine-nucleotide regulation of ATP-sensitive potassium channels in mouse pancreatic beta-cells and HIT cells.

Authors:  W F Hopkins; S Fatherazi; B Peter-Riesch; B E Corkey; D L Cook
Journal:  J Membr Biol       Date:  1992-09       Impact factor: 1.843

10.  Mechanism of cloned ATP-sensitive potassium channel activation by oleoyl-CoA.

Authors:  F M Gribble; P Proks; B E Corkey; F M Ashcroft
Journal:  J Biol Chem       Date:  1998-10-09       Impact factor: 5.157

View more
  27 in total

1.  Genetic Basis of Common Human Disease: Insight into the Role of Missense SNPs from Genome-Wide Association Studies.

Authors:  Lipika R Pal; John Moult
Journal:  J Mol Biol       Date:  2015-05-01       Impact factor: 5.469

2.  Heterozygous ABCC8 mutations are a cause of MODY.

Authors:  P Bowman; S E Flanagan; E L Edghill; A Damhuis; M H Shepherd; R Paisey; A T Hattersley; S Ellard
Journal:  Diabetologia       Date:  2011-10-12       Impact factor: 10.122

3.  Genetic variants in potassium channels are associated with type 2 diabetes in a Mongolian population.

Authors:  Zagaa Odgerel; Hee S Lee; Narnygerel Erdenebileg; Suren Gandbold; Munkhjargal Luvsanjamba; Nyamkhishig Sambuughin; Sainbileg Sonomtseren; Purevdulam Sharavdorj; Erdenezul Jodov; Khasag Altaisaikhan; Lev G Goldfarb
Journal:  J Diabetes       Date:  2012-09       Impact factor: 4.006

4.  Pharmacogenetics of Anti-Diabetes Drugs.

Authors:  Johanna K Distefano; Richard M Watanabe
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-01

Review 5.  K(ATP) channelopathies in the pancreas.

Authors:  Maria S Remedi; Joseph C Koster
Journal:  Pflugers Arch       Date:  2009-11-18       Impact factor: 3.657

6.  Disallowance of Acot7 in β-Cells Is Required for Normal Glucose Tolerance and Insulin Secretion.

Authors:  Aida Martinez-Sanchez; Timothy J Pullen; Pauline Chabosseau; Qifeng Zhang; Elizabeth Haythorne; Matthew C Cane; Marie-Sophie Nguyen-Tu; Sophie R Sayers; Guy A Rutter
Journal:  Diabetes       Date:  2016-02-09       Impact factor: 9.461

7.  The mitochondrial Ca2+ uniporter MCU is essential for glucose-induced ATP increases in pancreatic β-cells.

Authors:  Andrei I Tarasov; Francesca Semplici; Magalie A Ravier; Elisa A Bellomo; Timothy J Pullen; Patrick Gilon; Israel Sekler; Rosario Rizzuto; Guy A Rutter
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

Review 8.  Regulation of ATP production by mitochondrial Ca(2+).

Authors:  Andrei I Tarasov; Elinor J Griffiths; Guy A Rutter
Journal:  Cell Calcium       Date:  2012-04-12       Impact factor: 6.817

9.  Insulin gene mutations resulting in early-onset diabetes: marked differences in clinical presentation, metabolic status, and pathogenic effect through endoplasmic reticulum retention.

Authors:  Gargi Meur; Albane Simon; Nasret Harun; Marie Virally; Aurélie Dechaume; Amélie Bonnefond; Sabrina Fetita; Andrei I Tarasov; Pierre-Jean Guillausseau; Trine Welløv Boesgaard; Oluf Pedersen; Torben Hansen; Michel Polak; Jean-François Gautier; Philippe Froguel; Guy A Rutter; Martine Vaxillaire
Journal:  Diabetes       Date:  2009-12-10       Impact factor: 9.461

Review 10.  New insights into KATP channel gene mutations and neonatal diabetes mellitus.

Authors:  Tanadet Pipatpolkai; Samuel Usher; Phillip J Stansfeld; Frances M Ashcroft
Journal:  Nat Rev Endocrinol       Date:  2020-05-06       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.